Market Research Report

Global Gene Therapy Market Report By Vector (Non-Viral Vectors (Oligonucleotides, Other ,Non-Viral Vectors (Plasmids And RNAi)), Viral Vectors (Retroviral Vectors, Gammaretroviral Vectors, Lentiviral Vectors, Adeno-Associated Virus Vectors, Other Viral Vectors (Herpes Simplex And Adenoviral Vectors))), By Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, Other Indications (Retinal Diseases, Beta-Thalassemia, Peripheral Artery Disease, And Immune Deficiency Diseases)), By Delivery Method (In Vivo, Ex Vivo) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11218241
May 2022
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Gene Therapy Market is presumed to reach the market size of nearly USD 17.45 MN by 2028 from USD 7.7 MN in 2021 with a CAGR of 12.4% under the study period 2022 - 2028.

Gene therapy is a medical procedure to treat or prevent some underlying genetic problem. Instead of using drugs or surgery, gene therapy is used to treat a disorder by changing/ modifying a person's genetic makeup. Many gene therapies are being studied to ensure that they are both safe and effective. Genome editing is a promising technique that doctors hope to use to treat disorders in people in the near future.

Market Dynamics

The growing field of advanced therapies and gene delivery technologies has spawned a competitive environment in which a large number of market players are attempting to commercialize their gene therapy products. Although the high prices of currently available therapies encourage more development in this field, but are also responsible for limiting the accessibility and may lead to market withdrawals due to the lack of economic viability. Biopharma companies have taken a number of steps to gain a competitive advantage in the market. Companies are pursuing various market entry strategies, including expanding biopharmaceutical facilities, collaborating with other key stakeholders, and developing products with Contract Manufacturing Organizations (CMOs).

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gene therapy. The growth and trends of gene therapy industry provide a holistic approach to this study. 

Market Segmentation

This section of the gene therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Vector
  • Non-Viral Vectors (Oligonucleotides, Other Non-Viral Vectors (Plasmids And RNAi))
  • Viral Vectors (Retroviral Vectors, Gammaretroviral Vectors, Lentiviral Vectors, Adeno-Associated Virus Vectors, Other Viral Vectors (Herpes Simplex And Adenoviral Vectors))

By Indication
  • Neurological Diseases
  • Cancer
  • Duchenne Muscular Dystrophy
  • Hepatological Diseases
  • Other Indications (Retinal Diseases, Beta-Thalassemia, Peripheral Artery Disease, And Immune Deficiency Diseases)

By Delivery Method
  • In Vivo
  • Ex Vivo

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Gene Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Gene Therapy Market Share by Region (Representative Graph)

Global Gene Therapy Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene therapy market include Biogen (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Novartis AG (Switzerland), Amgen, Inc. (US), Spark Therapeutics, Inc. (US), MolMed S.p.A. (Italy), Orchard Therapeutics plc. (UK), Sibiono GeneTech Co. Ltd. (China), Alnylam Pharmaceuticals, Inc. (US), Human Stem Cells Institute (Russia), AnGes, Inc. (Japan), Dynavax Technologies (US), Jazz Pharmaceuticals, Inc. (Ireland), and Akcea Therapeutics (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Frequently Asked Questions (FAQs) about this Report

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . GENE THERAPY – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Vector
           3.7.2 Market Attractiveness Analysis By Indication
           3.7.3 Market Attractiveness Analysis By Delivery Method
           3.7.4 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL GENE THERAPY MARKET ANALYSIS BY VECTOR
       6.1 Overview by Vector
       6.2 Historical and Forecast Data
       6.3 Analysis by Vector
       6.4 Non-viral Vectors (Oligonucleotides, Other Non-viral Vectors (Plasmids And RNAi)) Historic and Forecast Sales by Regions
       6.5 Viral vectors (Retroviral Bectors, Gammaretroviral Vectors, Lentiviral Vectors, Adeno-associated Virus Vectors, Other Viral Vectors (Herpes Simplex And Adenoviral Vectors)) Historic and Forecast Sales by Regions
 
7 . GLOBAL GENE THERAPY MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical and Forecast Data
       7.3 Analysis by Indication
       7.4 Neurological Diseases Historic and Forecast Sales by Regions
       7.5 Cancer Historic and Forecast Sales by Regions
       7.6 Duchenne Muscular Dystrophy Historic and Forecast Sales by Regions
       7.7 Hepatological Diseases Historic and Forecast Sales by Regions
       7.8 Other Indications (Retinal Diseases, Beta-thalassemia, Peripheral Artery Disease, And Immune Deficiency Diseases) Historic and Forecast Sales by Regions
       7.9 ZWave Historic and Forecast Sales by Regions
 
8 . GLOBAL GENE THERAPY MARKET SALES ANALYSIS BY DELIVERY METHOD
       8.1 Overview by Delivery Method
       8.2 Historical and Forecast Data
       8.3 Analysis by Delivery Method
       8.4 In Vivo Historic and Forecast Sales by Regions
       8.5 Ex Vivo Historic and Forecast Sales by Regions
 
9 . GLOBAL GENE THERAPY MARKET SALES ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook Sales Analysis
       9.2. Introduction Sales Analysis
       9.3. North America Sales Analysis
           9.3.1. Overview, Historic and Forecast Sales Analysis
           9.3.2. North America By Segment Sales Analysis
           9.3.3. North America By Country Sales Analysis
           9.3.4. United State Sales Analysis
           9.3.5. Canada Sales Analysis
           9.3.6. Mexico Sales Analysis
       9.4. Europe Sales Analysis
           9.4.1. Overview, Historic and Forecast Sales Analysis
           9.4.2. Europe by Segment Sales Analysis
           9.4.3. Europe by Country Sales Analysis
           9.4.4. United Kingdom Sales Analysis
           9.4.5. France Sales Analysis
           9.4.6. Germany Sales Analysis
           9.4.7. Italy Sales Analysis
           9.4.8. Russia Sales Analysis
           9.4.9. Rest Of Europe Sales Analysis
       9.5. Asia Pacific Sales Analysis
           9.5.1. Overview, Historic and Forecast Sales Analysis
           9.5.2. Asia Pacific by Segment Sales Analysis
           9.5.3. Asia Pacific by Country Sales Analysis
           9.5.4. China Sales Analysis
           9.5.5. India Sales Analysis
           9.5.6. Japan Sales Analysis
           9.5.7. South Korea Sales Analysis
           9.5.8. Australia Sales Analysis
           9.5.9. Rest Of Asia Pacific Sales Analysis
       9.6. Latin America Sales Analysis
           9.6.1. Overview, Historic and Forecast Sales Analysis
           9.6.2. Latin America by Segment Sales Analysis
           9.6.3. Latin America by Country Sales Analysis
           9.6.4. Brazil Sales Analysis
           9.6.5. Argentina Sales Analysis
           9.6.6. Peru Sales Analysis
           9.6.7. Chile Sales Analysis
           9.6.8. Rest of Latin America Sales Analysis
       9.7. Middle East & Africa Sales Analysis
           9.7.1. Overview, Historic and Forecast Sales Analysis
           9.7.2. Middle East & Africa by Segment Sales Analysis
           9.7.3. Middle East & Africa by Country Sales Analysis
           9.7.4. Saudi Arabia Sales Analysis
           9.7.5. UAE Sales Analysis
           9.7.6. Israel Sales Analysis
           9.7.7. South Africa Sales Analysis
           9.7.8. Rest Of Middle East And Africa Sales Analysis
 
10 . COMPETITIVE LANDSCAPE OF THE GENE THERAPY COMPANIES
       10.1. Gene Therapy Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF GENE THERAPY INDUSTRY
       11.1. Top 10  Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Biogen (US)
           11.3.1. Company Overview
           11.3.2. Company Revenue
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Sarepta Therapeutics Inc. (US)
           11.4.1. Company Overview
           11.4.2. Company Revenue
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Gilead Sciences Inc. (US)
           11.5.1. Company Overview
           11.5.2. Company Revenue
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Novartis AG (Switzerland)
           11.6.1. Company Overview
           11.6.2. Company Revenue
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Amgen Inc. (US)
           11.7.1. Company Overview
           11.7.2. Company Revenue
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Spark Therapeutics Inc. (US)
           11.8.1. Company Overview
           11.8.2. Company Revenue
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. MolMed S.p.A. (Italy)
           11.9.1. Company Overview
           11.9.2. Company Revenue
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Orchard Therapeutics plc. (UK)
           11.10.1. Company Overview
           11.10.2. Company Revenue
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Sibiono GeneTech Co. Ltd. (China)
           11.11.1. Company Overview
           11.11.2. Company Revenue
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Alnylam Pharmaceuticals Inc. (US)
           11.12.1. Company Overview
           11.12.2. Company Revenue
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Human Stem Cells Institute (Russia)
           11.13.1. Company Overview
           11.13.2. Company Revenue
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. AnGes Inc. (Japan)
           11.14.1. Company Overview
           11.14.2. Company Revenue
           11.14.3. Products
           11.14.4. Recent Developments
       11.15. Dynavax Technologies (US)
           11.15.1. Company Overview
           11.15.2. Company Revenue
           11.15.3. Products
           11.15.4. Recent Developments
       11.16. Jazz Pharmaceuticals Inc. (Ireland)
           11.16.1. Company Overview
           11.16.2. Company Revenue
           11.16.3. Products
           11.16.4. Recent Developments
       11.17. Akcea Therapeutics (US)
           11.17.1. Company Overview
           11.17.2. Company Revenue
           11.17.3. Products
           11.17.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Vector (USD MN)
  •  Non-viral Vectors (Oligonucleotides, Other Non-viral Vectors (Plasmids And RNAi)) Market Sales by Geography (USD MN)
  •  Viral vectors (Retroviral Bectors, Gammaretroviral Vectors, Lentiviral Vectors, Adeno-associated Virus Vectors, Other Viral Vectors (Herpes Simplex And Adenoviral Vectors)) Market Sales by Geography (USD MN)
  •  Analysis Market by Indication (USD MN)
  •  Neurological Diseases Market Sales by Geography (USD MN)
  •  Cancer Market Sales by Geography (USD MN)
  •  Duchenne Muscular Dystrophy Market Sales by Geography (USD MN)
  •  Hepatological Diseases Market Sales by Geography (USD MN)
  •  Other Indications (Retinal Diseases, Beta-thalassemia, Peripheral Artery Disease, And Immune Deficiency Diseases) Market Sales by Geography (USD MN)
  •  ZWave Market Sales by Geography (USD MN)
  •  Analysis by Delivery Method (USD MN)
  •  In Vivo Market Sales by Geography (USD MN)
  •  Ex Vivo Market Sales by Geography (USD MN)
  •  Global Gene Therapy Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Gene Therapy Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Gene Therapy Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Vector
  •  Market Attractiveness Analysis by Indication
  •  Market Attractiveness Analysis by Delivery Method
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Vector (USD MN)
  •  Non-viral Vectors (Oligonucleotides, Other Non-viral Vectors (Plasmids And RNAi)) Market Sales by Geography (USD MN)
  •  Viral vectors (Retroviral Bectors, Gammaretroviral Vectors, Lentiviral Vectors, Adeno-associated Virus Vectors, Other Viral Vectors (Herpes Simplex And Adenoviral Vectors)) Market Sales by Geography (USD MN)
  •  Global Market Analysis by Indication (USD MN)
  •  Neurological Diseases Market Sales by Geography (USD MN)
  •  Cancer Market Sales by Geography (USD MN)
  •  Duchenne Muscular Dystrophy Market Sales by Geography (USD MN)
  •  Hepatological Diseases Market Sales by Geography (USD MN)
  •  Other Indications (Retinal Diseases, Beta-thalassemia, Peripheral Artery Disease, And Immune Deficiency Diseases) Market Sales by Geography (USD MN)
  •  ZWave Market Sales by Geography (USD MN)
  •  Global Market Analysis by Delivery Method (USD MN)
  •  In Vivo Market Sales by Geography (USD MN)
  •  Ex Vivo Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials